Form 8-K - Current report:
SEC Accession No. 0001615774-18-006280
Filing Date
2018-07-06
Accepted
2018-07-06 17:06:11
Documents
3
Period of Report
2018-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s111267_8k.htm 8-K 26652
2 EXHIBIT 1.1 s111267_ex1-1.htm EX-1.1 243005
3 EXHIBIT 5.1 s111267_ex5-1.htm EX-5.1 8222
  Complete submission text file 0001615774-18-006280.txt   279140
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 18942974
SIC: 8731 Services-Commercial Physical & Biological Research